Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence.

Skog, Oskar; Klingel, Karin; Roivainen, Merja; Korsgren, Olle

Skog, Oskar; Klingel, Karin; Roivainen, Merja; Korsgren, Olle.

Afiliação

Skog O; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory C11, Clinical Immunology, Uppsala University, Dag Hammarskjölds väg 20, 751 85, Uppsala, Sweden. oskar.skog@igp.uu.se.
Klingel K; Institute for Pathology and Neuropathology, University Hospital Tuebingen, Tuebingen, Germany.
Roivainen M; National Institute for Health and Welfare, Helsinki, Finland.
Korsgren O; Department of Immunology, Genetics and Pathology, The Rudbeck Laboratory C11, Clinical Immunology, Uppsala University, Dag Hammarskjölds väg 20, 751 85, Uppsala, Sweden.

Diabetologia ; 62(6): 1097-1099, 2019 06.

Article em En | MEDLINE | ID: mdl-30810767

Assuntos

Antivirais; Diabetes Mellitus Tipo 1; Infecções por Enterovirus; Enterovirus; Humanos; Vacinação

Palavras-chave

Autoimmunity; Beta cells; DiViD study; Enterovirus; Pancreas; Prevention; Type 1 diabetes; VP1; Virus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Enterovirus / Diabetes Mellitus Tipo 1 / Infecções por Enterovirus Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google